Testing effectiveness (Phase 2)Study completedNCT00323882
What this trial is testing
Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Who this might be right for
Prostate CancerNeoplasm Metastasis
Bristol-Myers Squibb 75